Send feedback

ITGB3 p.Pro433=

c.1299C>T · rs200857868 · VCV323866

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 5 submitters
gnomAD v4.1
Rare
rare (popmax 0.297%, mid)
Conditions
1
Glanzmann thrombasthenia

ClinGen expert panel — Platelet Disorders VCEP

Likely Benign for Glanzmann thrombasthenia. Applied ACMG criteria (verbatim):

BS1 BP7 BP4

Curation rationale (ClinGen, verbatim)

The NM_000212.2(ITGB3):c.1299C>T (p.Pro433=) synonymous variant was observed by Illumina as part of a predisposition screen in an ostensibly healthy population and has been reported in the literature in a healthy cohort (PMID: 27965976) but has not been reported in a Glanzmann thrombasthenia patient. In gnomAD v4.0.0 the minor allele frequency is 0.001910 (174/91086 alleles) in the South Asian population, which meets the BS1 threshold (>0.00158). Splicing prediction algorithms (MaxEntScan, HSF, and SpliceAI) predict no impact on splicing (BP4) and the nucleotide is not highly conserved (phyloP score 0.129449; BP7). In summary this variant meets criteria to be classified as likely benign. GT-specific criteria applied: BS1, BP4 and BP7.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.81GERP -2.9, phastCons 0.002
Overall
CADD6.796PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.297% Middle Eastern · 18/6,062 alleles
Filtering AF 0.192% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.159%
Overall 0.0469% 757/1,614,182 alleles · rare exomes 668/1,461,892 · genomes 89/152,290 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.297% 337
South Asian 0.191% 523
Admixed American 0.108% 923
Remaining individualsnot grpmax-eligible 0.0768% 1,302
European (non-Finnish) 0.0371% 2,694
Ashkenazi Jewishnot grpmax-eligible 0.0169% 5,922
African / African-American 0.012% 8,338

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ITGB3
Protein
p.Pro433=
Coding
c.1299C>T
MANE Select
NM_000212
dbSNP
rs200857868
Type
single nucleotide variant
Location
chr17:47292177 (GRCh38)
Gene constraint
LOEUF 0.685 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 87.19 · 125 PDB
Residue 433
a UniProt-annotated variant site (risk factor for fmait1; alloantigen mo(+))
Full ITGB3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Glanzmann thrombasthenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glanzmann thrombasthenia (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/itgb3-p-pro433 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown